This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université de Montréal directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $6,972,975
Evaluation of an asPirin-free strAtegy with ticagrelor in patieNts wiTH acutE corONary syndrome treated medically: the PANTHEON randomized controlled trial
CIHR · 2024 · Principal investigator
Evaluation of an asPirin-free strAtegy with ticagrelor in patieNts wiTH acutE corONary syndrome treated medically: the PANTHEON randomized controlled trial
Principal investigators: Marquis-Gravel, Guillaume; Bainey, Kevin R; Costa, Francesco; Tardif, Jean-Claude
Keywords: Acetylsalicylic Acid; Antiplatelet Therapy; Bleeding; Coronary Artery Disease; Myocardial Infarction; P2y12 Receptor Inhibitor; Patient-Oriented Trial; Pragmatic Trial; Randomized Controlled Trial; Ticagrelor
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.